1. Home
  2. EW vs RMD Comparison

EW vs RMD Comparison

Compare EW & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EW
  • RMD
  • Stock Information
  • Founded
  • EW 1958
  • RMD 1989
  • Country
  • EW United States
  • RMD United States
  • Employees
  • EW N/A
  • RMD N/A
  • Industry
  • EW Industrial Specialties
  • RMD Medical/Dental Instruments
  • Sector
  • EW Health Care
  • RMD Health Care
  • Exchange
  • EW Nasdaq
  • RMD Nasdaq
  • Market Cap
  • EW 44.8B
  • RMD 40.7B
  • IPO Year
  • EW 2000
  • RMD 1995
  • Fundamental
  • Price
  • EW $79.32
  • RMD $279.11
  • Analyst Decision
  • EW Buy
  • RMD Buy
  • Analyst Count
  • EW 20
  • RMD 13
  • Target Price
  • EW $85.00
  • RMD $276.82
  • AVG Volume (30 Days)
  • EW 5.1M
  • RMD 1.0M
  • Earning Date
  • EW 07-24-2025
  • RMD 07-31-2025
  • Dividend Yield
  • EW N/A
  • RMD 0.86%
  • EPS Growth
  • EW 188.87
  • RMD 37.43
  • EPS
  • EW 7.02
  • RMD 9.51
  • Revenue
  • EW $5,685,100,000.00
  • RMD $5,146,327,000.00
  • Revenue This Year
  • EW $12.97
  • RMD $8.76
  • Revenue Next Year
  • EW $9.65
  • RMD $7.16
  • P/E Ratio
  • EW $33.19
  • RMD $29.36
  • Revenue Growth
  • EW 9.49
  • RMD 9.84
  • 52 Week Low
  • EW $59.41
  • RMD $199.92
  • 52 Week High
  • EW $83.00
  • RMD $281.90
  • Technical
  • Relative Strength Index (RSI)
  • EW 56.40
  • RMD 71.02
  • Support Level
  • EW $75.39
  • RMD $271.64
  • Resistance Level
  • EW $81.88
  • RMD $278.86
  • Average True Range (ATR)
  • EW 1.78
  • RMD 5.37
  • MACD
  • EW 0.27
  • RMD 1.19
  • Stochastic Oscillator
  • EW 52.14
  • RMD 94.31

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: